Susquehanna raised the firm’s price target on RXO Inc. to $20 from $14 and keeps a Negative rating on the shares. The firm said its pro-forma analysis suggests Coyote adds meaningful value to RXO shares, but RXO-Coyote still looks expensive relative to comparable businesses post-deal.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO: